This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (17)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal

Sandra Y. Moody-Ayers, MD; Carolyn K. Wells, MPH; Alvan R. Feinstein, MD, MS

Arch Intern Med. 2000;160:1109-1115.

Background  Although the cure of breast cancer by "early detection" and prompt treatment rests on the belief that all breast cancers grow at the same rate, many cancers have been shown to grow rapidly and others slowly. In particular, mammography screening may often detect the slow-growing, nonaggressive tumors that might not be found until much later, if at all.

Methods  We reviewed the medical records of a natural cohort of 233 patients. The cohort comprised all women who received their first antineoplastic treatment for breast cancer at Yale–New Haven Hospital during the period from January 1 through December 31, 1988, and had a median follow-up thereafter of 82.4 months.

Results  The mammography screen–detected group (MSDG) contained 97 (42%) of the 233 breast cancers. The rates of subsequent freedom from cancer deaths or recurrences were 95% (92 patients) in the MSDG and 79% (107 patients) in all other patients (log-rank 2P<.001). This superiority occurred partly because 90 (93%) of the MSDG were in the good prognosis TNM stages 0, I, and IIA, compared with 92 (68%) of the non-MSDG (² 2P=.001). Of the 31 patients with stage 0 (carcinoma in situ), all of whom had disease-free survival, 24 (77%) were found by mammography screening. Even within similar TNM stages, however, the MSDG had distinctly better disease-free survival results than the non-MSDG. For patients in TNM stages I and IIA, the "failure events" had respective rates of 2% and 13% (log-rank 2P=.02).

Conclusions  The results suggest that many of the breast cancers found by mammography screening have excellent prognosis not just because of early detection, but also because many of the cancers are relatively benign, requiring minimal therapy.

From the Departments of Medicine (Drs Moody-Ayers and Feinstein and Ms Wells) and Epidemiology (Dr Feinstein), Yale University School of Medicine, New Haven, Conn. Dr Moody-Ayers is now with the Department of Medicine, University of North Carolina, Chapel Hill, NC.

RELATED ARTICLE

Archives of Internal Medicine Reader's Choice: Continuing Medical Education
Arch Intern Med. 2000;160(8):1206-1207.
FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Molecular Subtypes of Breast Cancers Detected in Mammography Screening and Outside of Screening
Sihto et al.
Clin. Cancer Res. 2008;14:4103-4110.
ABSTRACT | FULL TEXT  

Do Tumors Detected by Mammography Screening Have a Favorable Prognosis?
O'Regan
JAMA 2004;292:1062-1063.
FULL TEXT  

Risk for Distant Recurrence of Breast Cancer Detected by Mammography Screening or Other Methods
Joensuu et al.
JAMA 2004;292:1064-1073.
ABSTRACT | FULL TEXT  

Mammography and Computerized Decision Systems: A Review
ROQUE and ANDRE
Ann. N. Y. Acad. Sci. 2002;980:83-94.
ABSTRACT | FULL TEXT  

Survival of Blacks and Whites After a Cancer Diagnosis
Bach et al.
JAMA 2002;287:2106-2113.
ABSTRACT | FULL TEXT  

Dot Size, Lead Time, Fallibility, and Impact on Survival: Continuing Controversies in Mammography
Berlin
Am. J. Roentgenol. 2001;176:1123-1130.
FULL TEXT